First-in-human study of left ventricular remuscularization with induced pluripotent stem cell derived cardiomyocyte spheroids for severe ischemic heart failure patients: preliminary LAPiS study result
Event:
Heart Failure 2024
Topic:
Treatment
Session:
Chronic heart failure - treatment 1